ORBIMED ADVISORS LLC Insider Trading for November 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of ORBIMED ADVISORS LLC for November 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 27 2017 | LOXO | Loxo Oncology, Inc ... | ORBIMED ADVISORS LLC | Director | Sell | S | 75.00 | 267,000 | 20,025,000 | 1,191,000 | 1.5 M to 1.2 M (-18.31 %) |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 18,500,000 | 0 | 0 | |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 14.00 | 833,333 | 11,666,662 | 3,409,865 | 2.6 M to 3.4 M (+32.34 %) |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 2,576,532 | 0 | 2,576,532 | 0 to 2.6 M |
| Nov 20 2017 | LOXO | Loxo Oncology, Inc ... | ORBIMED ADVISORS LLC | Director | Sell | S | 76.23 | 8,377 | 638,579 | 1,458,000 | 1.5 M to 1.5 M (-0.57 %) |
| Nov 20 2017 | LOXO | Loxo Oncology, Inc ... | ORBIMED ADVISORS LLC | Director | Sell | S | 75.37 | 71,598 | 5,396,341 | 1,466,377 | 1.5 M to 1.5 M (-4.66 %) |
| Nov 20 2017 | LOXO | Loxo Oncology, Inc ... | ORBIMED ADVISORS LLC | Director | Sell | S | 74.49 | 100,045 | 7,452,352 | 1,537,975 | 1.6 M to 1.5 M (-6.11 %) |
| Nov 20 2017 | LOXO | Loxo Oncology, Inc ... | ORBIMED ADVISORS LLC | Director | Sell | S | 73.48 | 43,300 | 3,181,684 | 1,638,020 | 1.7 M to 1.6 M (-2.58 %) |
| Nov 20 2017 | LOXO | Loxo Oncology, Inc ... | ORBIMED ADVISORS LLC | Director | Sell | S | 72.46 | 46,680 | 3,382,433 | 1,681,320 | 1.7 M to 1.7 M (-2.70 %) |
| Nov 20 2017 | ASNS | Arsanis, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 2,232,014 | 0 | 0 | |
| Nov 20 2017 | ASNS | Arsanis, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 229,412 | 0 | 0 | |
| Nov 20 2017 | ASNS | Arsanis, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 736,648 | 0 | 0 | |
| Nov 20 2017 | ASNS | Arsanis, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 704,846 | 0 | 0 | |
| Nov 20 2017 | ASNS | Arsanis, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 66,667 | 0 | 0 | |
| Nov 20 2017 | ASNS | Arsanis, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 10.00 | 500,000 | 5,000,000 | 1,868,966 | 1.4 M to 1.9 M (+36.52 %) |
| Nov 20 2017 | ASNS | Arsanis, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 653,974 | 0 | 1,368,966 | 715 K to 1.4 M (+91.47 %) |
| Nov 20 2017 | ASNS | Arsanis, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 114,320 | 0 | 714,992 | 600.7 K to 715 K (+19.03 %) |
| Nov 20 2017 | ASNS | Arsanis, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 328,909 | 0 | 600,672 | 271.8 K to 600.7 K (+121.03 %) |
| Nov 20 2017 | ASNS | Arsanis, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 252,230 | 0 | 271,763 | 19.5 K to 271.8 K (+1,291.30 %) |
| Nov 20 2017 | ASNS | Arsanis, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 19,533 | 0 | 19,533 | 0 to 19.5 K |